Meyka Pro banner
Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (TRLV) Stock Overview

Explore Trulieve Cannabis Corp.’s financial performance, market position, analyst ratings, and future outlook.

TRLVNYSE
HealthcareDrug Manufacturers - Specialty & Generic
$11.10
$0.85(8.29%)
U.S. Market opens in 54h 52m

Trulieve Cannabis Corp. (TRLV)

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio-4.49
EPS (TTM)$-2.46
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$9.42
3 Months$8.41
1 Year Target$10.85

TRLV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Trulieve Cannabis Corp. (NYSE: TRLV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Trulieve Cannabis Corp.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TRLV on the NYSE shows an RSI of 73.15, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $10.85 for the NYSE listing.

Key metrics behind Trulieve Cannabis Corp.'s NYSE-traded stock include a P/E ratio of -4.49 and a market capitalization of 1.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TRLV on the NYSE.

Price Performance (NYSE: TRLV)

1-Day Change
8.29%
5-Day Change
15.50%
1-Month Change
23.88%
3-Month Change
40.86%
6-Month Change
78.46%
Year-to-Date (YTD) Change
27.73%
1-Year Change
40.33%
3-Year Change
194.43%
5-Year Change
-58.24%
All-Time (Max) Change
5.61%

Contact Information

850 298 8866
3494 Martin Hurst Road, Tallahassee, FL, 32312

Company Facts

50,000 Employees
IPO DateSep 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions